Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07140913RecruitingPhase 3
Testing KarXT for bipolar I mania with mood stabilizers
This study tests whether adding KarXT to lithium, valproate, or lamotrigine helps calm manic episodes in people with bipolar I disorder. It aims to see if the combination is safe and works better than the mood stabilizer alone.
Bentonville, ArkansasAges 18–65 - NCT07136181RecruitingPhase 1/Phase 2
Study of NBM-BMX for advanced uveal melanoma that has spread
This trial tests a new oral drug, NBM-BMX, for people with metastatic uveal melanoma (melanoma of the eye that has spread). It aims to see if the drug is safe and effective. You may join if you have already tried some treatments, including tebentafusp if you are HLA-A*02:01 positive.
Scottsdale, ArizonaAges 18 years+ - NCT07137338RecruitingPhase 1
Gene therapy for BAG3-related dilated cardiomyopathy
This trial tests a one-time gene therapy called RP-A701 for people with dilated cardiomyopathy caused by a BAG3 gene mutation. The goal is to see if it is safe and can improve heart function.
San Diego, CaliforniaAges 18–65 - NCT07137819RecruitingPhase 3
Veregen ointment for actinic keratosis on face or scalp
This study tests a herbal ointment (Veregen) for actinic keratosis, a common precancerous skin condition. The ointment is applied to the face or bald scalp. It may offer a new treatment option for mild to moderate spots.
StrausbergAges 18 years+ - NCT07137910RecruitingPhase 2
Study of AHB-137 for chronic hepatitis B
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
Beijing, Beijing MunicipalityAges 18–65 - NCT07140328RecruitingPhase 2
Testing a new inhaler for COPD symptoms
This trial tests two forms of a new medication (HSK39004) in people with COPD. The goal is to see if they help improve breathing and are safe. Eligible participants must be between 40 and 80, have moderate to severe COPD, and be able to stop other COPD treatments during the study.
Nanchang, JiangsuAges 40–80 - NCT07144761Recruiting
Patient feedback study on eyelid lift with Ziplyft™
This study tests a new device called Ziplyft™ for lifting excess eyelid skin. Researchers want to know how satisfied patients and surgeons are with the results.
Miami, FloridaAges 35 years+ - NCT07138196RecruitingPhase 1
Adrixetinib for hard-to-treat chronic GvHD
This trial tests an experimental drug called adrixetinib (Q702) for people with active chronic graft-versus-host disease that has not responded well to standard treatments. It aims to see if the drug can help control your symptoms when other options have stopped working.
BarcelonaAges 18 years+ - NCT06961227Recruiting
Comparing two breathing machine settings in the ICU
This trial compares two different ways a breathing machine can help you breathe. It uses a special imaging technique to see which method works better for patients in the intensive care unit.
SanliurfaAges 18 years+ - NCT07143812RecruitingPhase 1
Stem cell gene therapy for newly diagnosed glioblastoma
This trial tests a new stem cell-based gene therapy for people with newly diagnosed glioblastoma who have already received standard treatment. The goal is to see if it is safe and potentially effective.
Seongnam, KyunggidoAges 19–70 - NCT07142785Recruiting
Peeling or Not Peeling for Idiopathic Epiretinal Membrane Surgery
This study compares two surgical approaches for treating an idiopathic epiretinal membrane (a thin layer of scar tissue on the retina). It aims to see whether peeling the inner layer of the retina during surgery leads to better vision and fewer visual distortions.
Hangzhou, ZhejiangAges 18 years+ - NCT07136844Recruiting
Walking and arm movement study for nerve and muscle conditions
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
LiègeAges 18 years+ - NCT07142967Recruiting
MR-Linac radiotherapy for prostate cancer that returned after earlier radiation
This trial tests if a special MRI-guided radiotherapy machine (MR-Linac) can safely treat prostate cancer that has come back after previous radiation therapy. It may help men who have limited options and want to avoid more invasive treatments.
New York, New YorkAges 18 years+ - NCT07144332Recruiting
Does dialysis alone lower uric acid enough?
This study checks how well hemodialysis alone removes uric acid from the blood. It helps doctors decide if extra medicines are needed to lower uric acid in people on regular dialysis.
SohagAges 18 years+ - NCT07136506Recruiting
Walking and arm movement study in healthy volunteers
This study looks at how people walk and move their arms to gather normal movement patterns. It may help doctors better understand different movement conditions in the future.
LiègeAges 18 years+ - NCT07136610Recruiting
Feeding evaluation tool test for NICU babies
This trial tests a new tool to standardize feeding evaluations for babies in the NICU born between August 2025 and July 2026. If your baby starts oral feeding by July 15, 2026, they may be able to join.
Barrington, IllinoisAges Up to 1 year - NCT07143968RecruitingPhase 2
Resmetirom for people with MASLD and HIV
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
Birmingham, AlabamaAges 18 years+ - NCT07144839Recruiting
Personalized Pregnancy Care with Placental Risk Assessment
This study uses a placental risk assessment to create a personalized care plan for your pregnancy. It aims to improve outcomes for both you and your baby.
Portland, OregonAges 15–50 - NCT05467033RecruitingPhase 3
Desmopressin to improve safety after kidney biopsy
This trial tests whether desmopressin can make kidney biopsy safer by reducing bleeding risk. It compares safety outcomes after a biopsy in people who meet specific blood, medication, and health criteria.
BialystokAges 18–99 - NCT07134465Enrolling by invitationPhase 1
Drug interaction study of HSK31858 and itraconazole
This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.
ShanghaiAges 18–45 - NCT07132255Enrolling by invitation
Study of remote robot-assisted heart stent placement
This trial tests whether a doctor can use a robot to place a heart stent while being in a different location. It is designed for people who need a stent to open a blocked heart artery.
Jimsar, Xinjiang Uygur Autonomous RegionAges 18–80 - NCT07133477Recruiting
Fish oil for skin health
This study tests whether taking fish oil concentrate can improve skin function in adults who have sensitive, redness-prone skin. If you're between 35 and 65 and have skin that easily gets dry or red, this might be a good fit.
CardiffAges 35–65 - NCT07135284Recruiting
Testing the LibAirty System for Bronchiectasis at Home
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
Birmingham, AlabamaAges 21 years+ - NCT07126912Recruiting
Alcarisa filler for mid-face volume restoration
This trial tests a new hyaluronic acid filler called Alcarisa to restore volume in the mid-face (cheek area). It may be a good option if you are looking for a non-surgical way to treat moderate to significant cheek volume loss.
Tehran, Tehran ProvinceAges 30–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.